Tradestie Institutional Equity Comparison Engine

AARD vs SION โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AARD Overall Edge

AARD Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aardvark Therapeutics, Inc. Common Stock (AARD) driven by superior Momentum & Technical, Options & Structure while SION counters with relative strength in Growth & Margin. Fundamentally, AARD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SION at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AARD sits in UNCLASSIFIED (26th %ile IV; Dealer Gamma Walls on Pro) against SION sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AARD N/M vs SION N/M Fwd P/E
Growth & Margin Winner SION
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner AARD
1Y -88.4% vs -91.2% ยท 52W Pos 2% vs 0%
Options & Structure Winner AARD
UNCLASSIFIED (26th %ile IV) vs BREAKDOWN (10th %ile IV)
AARD NASDAQ
Aardvark Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$1.26
-5.26% 1D
Market Cap $33.3M
1M Return -66.67%
1Y Return -88.4%
Forward P/E N/M
Unified AI Score
57.5 / 100 HOLD
Tech 79.0 Fund 63.0 Flow 68.0 Mom 64.0
SION NASDAQ
Sionna Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.15
-5.56% 1D
Market Cap $155.2M
1M Return -19.15%
1Y Return -91.23%
Forward P/E N/M
Unified AI Score
45.6 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 67.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AARD -88.4% SION -91.23% Spread: +2.83 pp (AARD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AARD TTM Op. Margin: 0.0% SION TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AARD vs SION. Trailing 12-month operating profitability (AARD 0.0% vs SION 0.0%) and valuation multiples (AARD N/M vs SION N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AARD (2) vs SION (3)
Institutional Metric AARD SION Criterion Row Winner
Market Capitalization Scale $33.3M $155.2M Larger Scale SION
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -66.0% -39.0% Higher ROE SION
52-Week Range Position Momentum 2% ($1โ€“$17) 0% ($3โ€“$55) Stronger Trend AARD
Beta / 30D Volatility Risk Regime 4.09ฮฒ ยท 288% Vol 1.98ฮฒ ยท 78% Vol Lower Realized Risk SION
Unified Institutional Score Composite Signal 57.5 / 100 (HOLD) 45.6 / 100 (HOLD) Higher Composite AARD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AARD vs SION Buy Guide
AARD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AARD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SION BREAKDOWN
45d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live SION Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AARD nor SION registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.